home  |   contact us      
1629 K Street NW, Suite 300, Washington, DC 20006
Tel/Fax: 202.263.1100      ajl@lormanlawdc.com

Selected Publications
  • “Debate Over ‘Generic Biologics’ Poses Unique Challenges For Policy Makers,” 19 Washington Legal Foundation Legal Backgrounder, No. 13 (2004).

  • “The intersection between patent law and the US drug approval process,” in Building and Enforcing Intellectual Property Value (Globe White Page, London, 2003).

  • “Clinical Trials Face Heightened Scrutiny as Science and Commerce Appear to Merge,” 4 J. Biolaw & Business, No. 4 (2001).

  • "FDA/Patent Law Intersection: What's New With Hatch-Waxman" in Biotechnology Law:  Biotechnology Patents & Business Strategies in the New Millennium, (Practising Law Institute, 2001).

  • Co-author, "The Drug Wars: Generics and Pioneers Once Again Make Their Case to Congress," Boston Bar Association Health Law Section Newsletter (Summer 2001).

  • "Encouraging Improved Pesticide Formulations: Data Protection for Inert Ingredients," in Pesticide Formulation and Adjuvant Technology, Foy and Pritchard, eds. (CRC Press 1996).

  • “The Chemical Weapons Convention,” The National Law Journal (June 27, 1994).

  • “Food Standards and the Quest for Healthier Foods,” in Nutrition Labeling: Issues and Directions for the 1990’s, Porter and Earl, eds. (National Academy Press, 1990).

  • Co-author, “Tilting the Balance in Favor of Disclosure: The Scope of the Medical Records Exemption to the Federal Freedom of Information Act,” Food Drug Cosmetic Law Review 17 (1988).